Tauriga Sciences, Inc.
TAUG · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.01 | 0.07 | -0.01 |
| FCF Yield | -2.80% | -3.69% | -4.52% | -5.62% |
| EV / EBITDA | -8.13 | -10.76 | -18.28 | -12.14 |
| Quality | ||||
| ROIC | -165.91% | -99.74% | -62.09% | -110.79% |
| Gross Margin | 54.67% | 44.83% | 54.44% | 58.36% |
| Cash Conversion Ratio | 0.17 | 0.24 | 0.91 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.71% | 18.78% | 36.03% | 71.58% |
| Free Cash Flow Growth | 37.87% | 44.45% | 38.72% | -130.45% |
| Safety | ||||
| Net Debt / EBITDA | -1.13 | -1.18 | -1.02 | -0.28 |
| Interest Coverage | -19.95 | -2.85 | -2.24 | -9.74 |
| Efficiency | ||||
| Inventory Turnover | 0.13 | 0.16 | 0.07 | 0.05 |
| Cash Conversion Cycle | 220.15 | 360.34 | 357.45 | 829.59 |